Loading…

Browse All Grants

44,293 grants found

Filters
Reset

Showing 121140 of 44,293 grants

Active DISCOVERY AWARD GBP
How do phagocytes control phagosome fate and pathogen killing?
Wellcome Trust University of Sheffield United Kingdom 2025 – 2033

Our goal is to understand how phagocytic cells control how they kill different microbes. This core role of immune cells is key to preventing infections, but how pathogen processing...

£378.46M
GBP
Active DISCOVERY AWARD GBP
Clonal and functional T cell determinants of protection and pathogenesis in tuberculosis.
Wellcome Trust University College London United Kingdom 2024 – 2032

Tuberculosis (TB), resulting from infection with Mycobacterium tuberculosis (Mtb), kills 1.5 million people per year. The immune system prevents disease in most people who become i...

£374.55M
GBP
Active DISCOVERY AWARD GBP
Next generation genome annotation for eukaryotic pathogens and vectors, using artificial intelligence
Wellcome Trust University of Liverpool United Kingdom 2024 – 2030

High-quality gene annotation is of vital importance for meaningful interpretation of biological data. Current sequencing technologies permit production of high-quality genome assem...

£372.75M
GBP
Active DISCRETIONARY AWARD GBP
Data as a foundation for AI innovation and global discovery research in the life sciences
Wellcome Trust European Bioinformatics Institute United Kingdom 2025 – 2030

EMBL-EBI's data resources are a fundamental necessity for biomolecular research. Through open data, there is tremendous potential for accelerating scientific understanding and prod...

£363.35M
GBP
Active RESEARCH GBP
A randomised trial of adjuvant rituximab in young people with Graves’ disease
National Institute for Health and Care Research University of Newcastle Upon Tyne United Kingdom 2024 – 2030

Research Question Does a single dose of rituximab administered shortly after diagnosis, in addition to a 2-year course of thionamide antithyroid drug treatment, increase remission...

£361.08M
GBP
Completed RESEARCH GBP
HElping Alleviate the Longer-term consequences of COVID-19 (HEAL-COVID): A national platform trial
National Institute for Health and Care Research University of Cambridge United Kingdom 2021 – 2025

Research question: Can interventions in the convalescent phase of COVID-19 improve longer-term outcomes? Background: COVID-19 is a new disease for which the natural history re...

£360.74M
GBP
Active RESEARCH GBP
A UK multi-centre cluster randomised control trial, with internal pilot, of the ADVANCE-Digitally supported perpetrator intervention compared to community justice offender management (1:1), to reduce intimate partner violence (IPV), for men convicted of IPV who misuse substances (ADVANCE-D trial)
National Institute for Health and Care Research King's College London United Kingdom 2023 – 2027

RESEARCH QUESTION Is ADVANCE-D for men who misuse substances serving a community sentence or who are on license for intimate partner violence (IPV) perpetration superior in reduci...

£355.04M
GBP
Active INFRASTRUCTURE GBP
NIHR Oxford Health Biomedical Research Centre
National Institute for Health Research Oxford Health Nhs Foundation Trust United Kingdom 2022 – 2027

Improving brain health: the future in mind One in four people will experience mental illnesses in their lifetime. Whilst some recover completely, many struggle for years with sympt...

£353.55M
GBP
Active INFRASTRUCTURE GBP
Great Ormond Street Hospital BRC
National Institute for Health Research Great Ormond Street Hospital for Childre... United Kingdom 2022 – 2027

The NIHR Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC) in partnership with the University College London (UCL) Great Ormond Street Institute of Child Health...

£352.95M
GBP
Completed RESEARCH GBP
Spinal Immobilisation Study (SIS)
National Institute for Health and Care Research Imperial College London United Kingdom 2022 – 2025

RESEARCH QUESTION: Is movement minimisation non-inferior (i.e. not unacceptably worse) compared to triple immobilisation in relation to functional outcome (as assessed by the Funct...

£349.78M
GBP
Active DISCOVERY AWARD GBP
Characterisation of the immunological mechanisms that drive chronic chikungunya disease pathogenesis
Wellcome Trust Institut Pasteur Cambodia United Kingdom 2024 – 2030

Chikungunya virus (CHIKV) represents a widespread mosquito-transmitted, arthritogenic virus that causes chronic debilitating joint pain and arthritis in almost half of infected pat...

£348.39M
GBP
Active CAREER DEVELOPMENT AWARD GBP
From cells and synapses to connectivity and cure in paediatric autoimmune encephalitis
Wellcome Trust Aston University United Kingdom 2025 – 2033

Worldwide, one person every minute is diagnosed with encephalitis. An autoimmune cause is now as common as infectious (~27%). Autoimmune encephalitis (AE) patient outcomes remain s...

£344.71M
GBP
Active RESEARCH GBP
ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC - TOURIST
National Institute for Health and Care Research The Christie Nhs Foundation Trust United Kingdom 2023 – 2028

Background Non-Small Cell Lung Cancer (NSCLC) is the leading global cause of cancer death with an incidence of >1.2 million; 70% of patients present with incurable disease with tr...

£343.13M
GBP
Active MENTAL HEALTH AWARD: UNDERSTANDING ANXIETY AND TRAUMA GBP
When your body betrays you: interoceptive mechanisms of anxiety after cancer
Wellcome Trust The Leanne Pero Foundation United Kingdom 2024 – 2029

There is unequivocal evidence that cancer causes anxiety. For some, anxiety resolves following successful cancer treatment. For others, anxiety persists. As cancer survival rates h...

£333.83M
GBP
Active STRENGTHENING HEALTH AND DISEASE MODELLING FOR PUBLIC HEALTH DECISION MAKING GBP
CAMMISA: Climate-focused Analytics and Modelling for Mosquito-borne Infections in Southern Africa
Wellcome Trust Clinton Health Access Initiative United Kingdom 2025 – 2030

The widespread manifestation of climate change with trends in seasonality and extreme climate events have important implications for Mosquito-Borne Diseases (MBD). The transmission...

£330.83M
GBP
Active RESEARCH GBP
Sepsis Trials In Critical Care (SepTIC)
National Institute for Health and Care Research Imperial College London United Kingdom 2022 – 2027

Research questions: 1. Do rapid PCR-based microbiological diagnostics combined with procalcitonin improve outcomes and antibiotic stewardship compared to standard care in patien...

£329.54M
GBP
Active CAREER DEVELOPMENT AWARD GBP
Defining the molecular mechanisms underlying sex-differences in the maintenance of hearing.
Wellcome Trust King's College London United Kingdom 2022 – 2030

Sex impacts the maintenance of hearing over the life course. Onset, severity, and prevelance of age-related/adult-onset hearing loss (ARHL) are not equivalent in men and women, so...

£327.36M
GBP
Active DISCRETIONARY AWARD GBP
Accelerating Action for Extreme Heat and Health
Wellcome Trust World Health Organization, Switzerland United Kingdom 2022 – 2027

Within the overall Wellcome Trust-WHO strategic partnership on climate change and health, this project aims to significantly strengthen multidisciplinary capacity and partnerships...

£324.08M
GBP
Active RESEARCH GBP
CLArithromycin for post-Stroke Pneumonia (CLASP): A prospective, randomised open-label blinded-endpoint (PROBE) phase 3 multicentre trial
National Institute for Health and Care Research University of Glasgow United Kingdom 2024 – 2029

Research question In people with post-stroke pneumonia (PSP), does addition of the immunomodulatory macrolide antibiotic clarithromycin to usual non-macrolide antibiotic treatment...

£323.86M
GBP
Active RESEARCH GBP
Rose-NET: Manchester-Leeds Collaborative National Evaluation Team
National Institute for Health and Care Research The University of Manchester United Kingdom 2024 – 2029

Aims Our Rose-NET National Evaluation Team aims to conduct national evaluations of health and care innovations. We define innovation as ‘a novel set of behaviours, routines, and...

£323.28M
GBP